Latest Updates

CCRAS have conducted pilot studies which have proved the clinical safety and efficacy of the drug

Over 1,300 delegates are expected to take part in the conference.

The guide aims to offer a consistent interpretation of the latest FDA and EMA guidance.

The company is also evaluating the potential for conducting studies with GBR 830 for the treatment of other inflammatory…

Customers and industry stakeholders will participate in a day-long event complete with a tour of the new plant and visit Maher…

Teaotia has asked the state government to prepare strategy for increasing exports from the state Union Commerce Secretary Rita…

The theme for this year's conference is 'Clinical pharmacology contributing to Global Health and Policies

Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences

The company divests its rare disease gene therapy drugs to Orchard Therapeutics

The new facility would allow its Sanofi Pasteur division to meet the growing demand of five-component acellular pertussis (5-acP)…